UB 165 fumarate
Cat. No. 1348
Chemical Name: 2-(6-Chloro-3-pyridinyl)-9-azabicyc
Biological ActivitySubtype-selective nicotinic agonist. Full agonist at α3β2- and very weak partial agonist at α4β2- containing nAChRs. Ki values are 0.27, 20 (IC50), 2790 and 990 nM for α4β2, α3, α7 and α1β1δε respectively.
Licensing InformationSold with the permission of the University of Bristol
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Cao et al (2005) Different nicotinic acetylcholine receptor subtypes mediating striatal and prefrontal cortical [3H]dopamine release. Neuropharmacology 48 72. PMID: 15617729.
Sharples et al (2000) UB-165: a novel agonist with subtype selectivity implicates the α4β2 subtype in the modulation of dopamine release from rat striatal synaptosomes. J.Neurosci. 20 2783. PMID: 10751429.
Wright et al (1997) Synthesis of UB-165: a novel nicotinic ligand and anatoxin-a/epibatidine hybrid. Bioorg.Med.Chem.Lett. 7 2867.
If you know of a relevant reference for UB 165 fumarate please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses UB 165 fumarate from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: UB 165 fumarate, supplier, Subunit, selective, nAChR, agonists, Acetylcholine, Nicotinic, Receptors, Non-Selective, Subtypes, Other, UB165, Tocris Bioscience, Nicotinic Receptor (Other Subtype) Agonist products
Find multiple products by catalog number
New Products in this Area
Potent positive allosteric modulator of α4β2 nAChRs; also inhibitor of (α4)2(β2)3, muscle-type and Torpedo nAChRs
Follow Tocris on LinkedIn
Visit our LinkedIn page for the latest Tocris news, events and updates.